Tibolone: additional cost negligible in postmenopausal women

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.295, 2001-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tibolone: additional cost negligible in postmenopausal women

Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

By Willis M.

Clinical Drug Investigation, Vol. 21, Iss. 2, 2001-02 ,pp. : 115-127

Adis International

Access to resources Recommend Favorite

Tibolone a double-edged sword for postmenopausal women

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Tibolone: favourable cardiovascular effects in postmenopausal women

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Tibolone has beneficial effects on the lipoprotein profile of postmenopausal women

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite